+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Ursodeoxycholic acid increases tumor incidence in MIN mice



Ursodeoxycholic acid increases tumor incidence in MIN mice



Gastroenterology 108(4 Suppl. ): A503




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 034144857

Download citation: RISBibTeXText


Related references

Ursodeoxycholic acid complexation with 2-hydroxypropyl-beta-cyclodextrin increases ursodeoxycholic acid biliary excretion after single oral administration in rats. Journal of Hepatology 28(Suppl. 1): 126, 1998

Ursodeoxycholic acid complexation with 2-hydroxypropyl-beta-cyclodextrin increases ursodeoxycholic acid biliary excretion after single oral administration in rats. Pharmacology 62(2): 107-112, 2001

Treatment with ursodeoxycholic acid, but not with cholic acid, increases bile flow independently of cystic fibrosis transmembrane regulator in mice. 2007

Correcting biliary phenotype in cystic fibrosis mice Nor-ursodeoxycholic acid , but not UDCA, normalizes hepatic bile pH and increases bile flow in G551D CF mice. Hepatology 36(4 Part 2): 337A, 2002

Inhibition of ursodeoxycholic acid induced hypercholeresis by sodium replacement or amiloride is associated with replacement of unconjugated ursodeoxycholic acid by ursodeoxycholic acid glucuronides in bile. Hepatology 5(5): 1010, 1985

Melatonin increases both life span and tumor incidence in female CBA mice. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 56(7): B311-B323, 2001

Evidence that ursodeoxycholic acid increases biliary excretion of cholic acid and chenodeoxycholic acid in man. Gastroenterology 106(4 Suppl. ): A935, 1994

Effect of ursodeoxycholic acid on expression of Fas ligand and tumor necrosis factor-alpha in the liver of mice with acute graft-versus-host disease. Current Therapeutic Research 61(11): 825-836, 2000

Conversion of 7-ketolithocholic acid to ursodeoxycholic acid by human intestinal anaerobic microorganisms: interchangeability of chenodeoxycholic acid and ursodeoxycholic acid. Gastroenterologia Japonica 14(5): 417-424, 1979

D22-ursodeoxycholic acid, a unique metabolite of administered ursodeoxycholic acid in rats, indicating partial b-oxidation as a major pathway for bile acid metabolism. Biochemistry (American Chemical Society) 34: 69-78, 1995

DELTA-22-ursodeoxycholic acid, a unique metabolite of administered ursodeoxycholic acid in rats, indicating partial beta-oxidation as a major pathway for bile acid metabolism. Biochemistry. 34(13): 4169-4178, 1995

Efficacy and safety of ursodeoxycholic acid for dissolution of gallstone fragments comparison with the combination of ursodeoxycholic acid and chenodeoxycholic acid. Hepatology 14(6): 1136-1141, 1991

Efficacy and safety of a combination of chenodeoxycholic acid and ursodeoxycholic acid for gallstone dissolution: a comparison with ursodeoxycholic acid alone. Gastroenterology 96(1): 222-229, 1989

Ursodeoxycholic acid inhibits tumor development during both AOM-induced colon tumor initiation and progression. Gastroenterology 120(5 Suppl. 1): A 255, 2001